Botanical species · safety record

Yucca filamentosa

The EFSA Compendium of Botanicals holds 5 constituent measurements for Yucca filamentosa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Yucca filamentosa L.

5Constituent measurements
0Safety records
4Cited sources
34Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 34 licensed products naming Yucca filamentosa as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Flower
  • Leaf/Leaves
  • Plante entière
  • Root
  • Root (powder)
  • Whole plant

What the records describe

Constituents measured

  • Steroidal saponins2
  • Hecogenin1
  • Saponins1
  • Tannins1

Plant parts

  • Leaves2
  • Roots and other underground parts2
  • Unspecified1

Preparations

  • Solvent extraction4

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Steroidal saponinsRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
Steroidal saponinsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
HecogeninUnspecifiedNo resolvable identifier
SaponinsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
TanninsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Kintya, P.K., Dragalin, I.P., Chirva, V.Ya. Steroid saponins III. Glycosides A and B from Yucca filamentosa. Chemistry of natural compounds, 1974, vol. 8, no. 5, p. 584-586. DOI
  2. DRAGALIN, IP., KINTIA, PK. STEROIDAL SAPONINS OF YUCCA-FILAMENTOSA - YUCCOSIDE-C AND PROTOYUCCOSIDE-C . Phytochemistry, 1975, vol. 14, no. 8, p. 1817-1820. DOI
  3. Hamed, M., El-Amin, S., Abdel-Fattah, A.S. Isolation and identification of some compounds from molluscicidaly active plant Yucca filamentosa Marginata. Pharmacologyonline, 2015, vol. 1, p. 19-30.
  4. Wu, Chao-Hua. Steroid sapogenins in some Chinese medicinal plants. II. Yaoxue xuebao, 1960, vol. 8, p. 66-9.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue